{"pageProps": {"talksPageBanner": {"banner": {"title": "TP WorkLife 10/12", "slug": "tp-worklife-10-12", "bannerLocation": "talks", "displayToExistingMembers": true, "mainContentHeadline": "The podcast where science meets business", "mainContent": "From fixing meetings to finding a mentor, get new insights to help you enjoy your time at work and thrive in your career.", "buttonLabel": "Listen now", "buttonLink": "https://www.ted.com/podcasts/fixable?utm_medium=website&utm_source=talkpage&utm_campaign=podcasts&utm_content=04112023-fixabletp", "showButtonIcon": false, "backgroundColor": "#FFEFA1", "textColor": "#000000", "useBackgroundGradient": false, "imageMobileBreakpoint": {"metadata": {"tags": []}, "sys": {"space": {"sys": {"type": "Link", "linkType": "Space", "id": "ab732rbh901q"}}, "id": "4BM5OASbSYegLKRYSri2gZ", "type": "Asset", "createdAt": "2023-10-11T21:22:04.069Z", "updatedAt": "2023-10-11T21:22:04.069Z", "environment": {"sys": {"id": "master", "type": "Link", "linkType": "Environment"}}, "revision": 1, "locale": "en-US"}, "fields": {"title": "WorkLife S6 - 659 x 1052x", "description": "", "file": {"url": "//images.ctfassets.net/ab732rbh901q/4BM5OASbSYegLKRYSri2gZ/c0a7605eca821fae7eea6c0359347d83/WorkLife_S6_-_659_x_1052x.png", "details": {"size": 29801, "image": {"width": 1318, "height": 210}}, "fileName": "WorkLife S6 - 659 x 1052x.png", "contentType": "image/png"}}}, "imageTabletBreakpoint": {"metadata": {"tags": []}, "sys": {"space": {"sys": {"type": "Link", "linkType": "Space", "id": "ab732rbh901q"}}, "id": "5DcAOXZmqMRBDk1Tb4tn87", "type": "Asset", "createdAt": "2023-10-11T21:25:23.492Z", "updatedAt": "2023-10-11T21:25:23.492Z", "environment": {"sys": {"id": "master", "type": "Link", "linkType": "Environment"}}, "revision": 1, "locale": "en-US"}, "fields": {"title": "WorkLife S6 - 1019 x 1602x (1)", "description": "", "file": {"url": "//images.ctfassets.net/ab732rbh901q/5DcAOXZmqMRBDk1Tb4tn87/11640e45662ad7292d8eb536a0de3f1e/WorkLife_S6_-_1019_x_1602x__1_.png", "details": {"size": 45372, "image": {"width": 2038, "height": 320}}, "fileName": "WorkLife S6 - 1019 x 1602x (1).png", "contentType": "image/png"}}}, "imageDesktopBreakpoint": {"metadata": {"tags": []}, "sys": {"space": {"sys": {"type": "Link", "linkType": "Space", "id": "ab732rbh901q"}}, "id": "3toTf7QHhGfKy59Qcx69dk", "type": "Asset", "createdAt": "2023-10-11T21:22:04.076Z", "updatedAt": "2023-10-11T21:22:04.076Z", "environment": {"sys": {"id": "master", "type": "Link", "linkType": "Environment"}}, "revision": 1, "locale": "en-US"}, "fields": {"title": "WorkLife S6 - 385 x 1052x", "description": "", "file": {"url": "//images.ctfassets.net/ab732rbh901q/3toTf7QHhGfKy59Qcx69dk/9b35ad517313f033f03f743e335118d5/WorkLife_S6_-_385_x_1052x.png", "details": {"size": 26833, "image": {"width": 770, "height": 210}}, "fileName": "WorkLife S6 - 385 x 1052x.png", "contentType": "image/png"}}}, "imageXLBreakpoint": {"metadata": {"tags": []}, "sys": {"space": {"sys": {"type": "Link", "linkType": "Space", "id": "ab732rbh901q"}}, "id": "3M4ANHhDr3Nwsd385dCSFK", "type": "Asset", "createdAt": "2023-10-11T21:22:04.078Z", "updatedAt": "2023-10-11T21:22:04.078Z", "environment": {"sys": {"id": "master", "type": "Link", "linkType": "Environment"}}, "revision": 1, "locale": "en-US"}, "fields": {"title": "WorkLife S6 - 472 x 1072x", "description": "", "file": {"url": "//images.ctfassets.net/ab732rbh901q/3M4ANHhDr3Nwsd385dCSFK/9d558d98ba8cbc09bb163323934ccd10/WorkLife_S6_-_472_x_1072x.png", "details": {"size": 27426, "image": {"width": 944, "height": 202}}, "fileName": "WorkLife S6 - 472 x 1072x.png", "contentType": "image/png"}}}}, "status": "published"}, "preview": false, "shortenedUrl": "https://go.ted.com/6wrK", "action": null, "videoData": {"__typename": "Video", "id": "75479", "slug": "kiran_mazumdar_shaw_the_global_cooperation_that_accelerated_the_covid_19_vaccines", "title": "The global cooperation that accelerated the COVID-19 vaccines", "socialTitle": "The global cooperation that accelerated the COVID-19 vaccines", "presenterDisplayName": "Kiran Mazumdar-Shaw", "internalLanguageCode": "en", "commentsEnabled": false, "commentsLoggedInOnly": false, "recordedOn": "2021-03-12", "curatorApproved": true, "viewedCount": 558340, "duration": 850, "publishedAt": "2021-04-20T14:40:57Z", "topics": {"__typename": "TopicConnection", "nodes": [{"__typename": "Topic", "id": "8", "name": "science", "slug": "science"}, {"__typename": "Topic", "id": "46", "name": "collaboration", "slug": "collaboration"}, {"__typename": "Topic", "id": "60", "name": "health care", "slug": "health+care"}, {"__typename": "Topic", "id": "226", "name": "public health", "slug": "public+health"}, {"__typename": "Topic", "id": "239", "name": "Vaccines", "slug": "vaccines"}, {"__typename": "Topic", "id": "312", "name": "medical research", "slug": "medical+research"}, {"__typename": "Topic", "id": "338", "name": "pandemic", "slug": "pandemic"}, {"__typename": "Topic", "id": "355", "name": "india", "slug": "india"}, {"__typename": "Topic", "id": "4648", "name": "coronavirus", "slug": "coronavirus"}]}, "talkExtras": {"__typename": "TalkExtras", "recommendations": [{"__typename": "Recommendation", "blurb": "More resources curated by Kiran Mazumdar-Shaw", "recLists": [{"__typename": "RecommendationList", "title": "", "description": "", "recItems": [{"__typename": "RecommendationItem", "blurb": "You can learn more about Kiran Mazumdar-Shaw's work on her [blog](https://kiranshaw.blog/), [YouTube channel](http://www.youtube.com/Kiranmazumdarshaw), [Facebook page](https://www.facebook.com/KiranShaw1/), [LinkedIn](https://www.linkedin.com/in/kmazumdarshaw/), [Twitter]( https://twitter.com/kiranshaw) and [Biocon profile](https://www.biocon.com/about-us/board-of-directors-biocon/kiran-mazumdar-shaw-biocon/). Reach out to her at kiran.mazumdar@biocon.com.", "eyebrow": "", "headline": "Follow Kiran Mazumdar-Shaw's work", "isPdf": false, "label": "EXPLORE", "linkUrl": "", "note": ""}]}]}], "takeAction": [{"__typename": "TakeActionModule", "blurb": "**Learn more** about Kiran Mazumdar-Shaw's work and thoughts on innovation.", "endAt": null, "eyebrow": null, "linkUrl": "https://kiranshaw.blog/", "published": true, "startAt": null, "status": "APPROVED", "verb": "learn", "visibleUrl": "kiranshaw.blog"}], "learnModules": []}, "primaryImageSet": [{"__typename": "PhotoSize", "url": "https://talkstar-photos.s3.amazonaws.com/uploads/7347a056-4a73-4993-8b50-ed18eeaf0dc1/KiranMazumdar-Shaw_2021S-embed.jpg", "aspectRatioName": "16x9"}, {"__typename": "PhotoSize", "url": "https://talkstar-photos.s3.amazonaws.com/uploads/bde860c3-4816-4dc3-a166-fceb3a8e83d7/KiranMazumdar-Shaw_2021S-1350x675.jpg", "aspectRatioName": "2x1"}, {"__typename": "PhotoSize", "url": "https://talkstar-photos.s3.amazonaws.com/uploads/4c87ead8-d96b-40f3-bd00-1d9dcf586424/KiranMazumdar-Shaw_2021S-stageshot.jpg", "aspectRatioName": "4x3"}], "relatedVideos": [{"__typename": "Video", "slug": "johanna_benesty_what_it_takes_to_crush_a_pandemic", "id": "68728"}, {"__typename": "Video", "slug": "dan_kwartler_how_fast_can_a_vaccine_be_made", "id": "64051"}, {"__typename": "Video", "slug": "heidi_larson_why_rumors_about_vaccines_spread_and_how_to_rebuild_trust", "id": "65389"}], "customContentDetails": {"__typename": "CustomContentDetails", "partnerName": null}, "speakers": {"__typename": "AcmeSpeakerConnection", "nodes": [{"__typename": "AcmeSpeaker", "photoUrl": "https://pe.tedcdn.com/images/ted/9045b428f4517a95f94c4f6443f6ab0f13031409_254x191.jpg", "firstname": "Kiran", "middlename": "", "lastname": "Mazumdar-Shaw", "description": "Biotech entrepreneur", "isLive": true, "title": "", "whatOthersSay": "", "whoTheyAre": "Kiran Mazumdar-Shaw is a biotech entrepreneur, health care visionary, global influencer and passionate philanthropist.", "whyListen": "<p>Kiran Mazumdar-Shaw is a biotech industry pioneer and founder of Biocon, an innovation-led global biopharmaceutical company. She is the proud recipient of two of India&#39;s highest civilian honors: the Padma Shri and Padma Bhushan. She has been conferred with the EY World Entrepreneur of the Year 2020 Award. She has also been appointed the vice chair of the US-India Business Council in 2021. Mazumdar-Shaw&nbsp;has many other international accolades to her credit, including Australia&#39;s highest civilian honor, the Order of Australia, awarded in 2020, as well as the Knight of the Legion of Honour in 2016 and Othmer Gold Award 2014. She serves on the boards of Massachusetts Institute of Technology (MIT), PureTech Health, Infosys and Narayana Health.</p>", "slug": "kiran_mazumdar_shaw"}, {"__typename": "AcmeSpeaker", "photoUrl": "https://pe.tedcdn.com/images/ted/d1ed3eac725f9fb78aeb264944dbeb84487fcdd7_254x191.jpg", "firstname": "Simone", "middlename": "", "lastname": "Ross", "description": "TED technology curator", "isLive": true, "title": "", "whatOthersSay": "", "whoTheyAre": "Simone Ross has spent her career observing companies, individuals and ideas at the intersection of tech, the economy and society.", "whyListen": "<p>Simone Ross has been an active observer of the companies, individuals and ideas at the intersection of technology, the economy and society for over 20 years. She regularly advises companies on their content and conference strategy, specializing in designing programs and convening substantive conversations that connect the people and ideas at the intersection of tech and pretty much everything.</p><p>As the cofounder and chief program officer of&nbsp;<a href=\"https://techonomy.com/\" target=\"_blank\">Techonomy Media</a>,&nbsp;Ross was responsible for all program content and served as executive producer for the Techonomy conferences (Techonomy Bio, Techonomy Detroit, Techonomy Health, Techonomy NYC, Techonomy Policy and the annual Techonomy flagship conference).</p><p>Prior to Techonomy, Ross was program director for Fortune&#39;s conference division and director of programs and operations at the Computerworld Smithsonian Information Technology Awards Program, a nonprofit endeavor that helped the Smithsonian&#39;s National Museum of American History chronicle the information age revolution.</p>", "slug": "simone_ross"}]}, "description": "(This virtual conversation, hosted by TED technology curator Simone Ross, was recorded March 12, 2021.) Biotech entrepreneur Kiran Mazumdar-Shaw shares lessons learned from the global effort to develop COVID-19 vaccines: namely, the power of collaboration and the importance of equitable access to health care. Learn more about the innovative partnerships that helped create the vaccines -- and how India became a crucial player in the supply chain delivering millions of doses to the world.", "socialDescription": "(This virtual conversation, hosted by TED technology curator Simone Ross, was recorded March 12, 2021.) Biotech entrepreneur Kiran Mazumdar-Shaw shares lessons learned from the global effort to develop COVID-19 vaccines: namely, the power of collaboration and the importance of equitable access to health care. Learn more about the innovative partnerships that helped create the vaccines -- and how India became a crucial player in the supply chain delivering millions of doses to the world.", "partnerName": "BCG", "playerData": "{\"id\":\"75479\",\"mediaIdentifier\":\"consus-pm7143-im2346\",\"mediaProjectVersionIdentifier\":\"consus-pm7143-im2346\",\"duration\":859,\"languages\":[{\"languageName\":\"English\",\"endonym\":\"English\",\"languageCode\":\"en\",\"ianaCode\":\"en\",\"isRtl\":false},{\"languageName\":\"French\",\"endonym\":\"Fran\u00e7ais\",\"languageCode\":\"fr\",\"ianaCode\":\"fr\",\"isRtl\":false},{\"languageName\":\"Spanish\",\"endonym\":\"Espa\u00f1ol\",\"languageCode\":\"es\",\"ianaCode\":\"es\",\"isRtl\":false},{\"languageName\":\"Portuguese, Brazilian\",\"endonym\":\"Portugu\u00eas brasileiro\",\"languageCode\":\"pt-br\",\"ianaCode\":\"pt-BR\",\"isRtl\":false},{\"languageName\":\"Portuguese\",\"endonym\":\"Portugu\u00eas de Portugal\",\"languageCode\":\"pt\",\"ianaCode\":\"pt\",\"isRtl\":false},{\"languageName\":\"Arabic\",\"endonym\":\"\u0627\u0644\u0639\u0631\u0628\u064a\u0629\",\"languageCode\":\"ar\",\"ianaCode\":\"ar\",\"isRtl\":true},{\"languageName\":\"Chinese, Traditional\",\"endonym\":\"\u4e2d\u6587 (\u7e41\u9ad4)\",\"languageCode\":\"zh-tw\",\"ianaCode\":\"zh-Hant\",\"isRtl\":false},{\"languageName\":\"Vietnamese\",\"endonym\":\"Ti\u1ebfng Vi\u1ec7t\",\"languageCode\":\"vi\",\"ianaCode\":\"vi\",\"isRtl\":false},{\"languageName\":\"Chinese, Simplified\",\"endonym\":\"\u4e2d\u6587 (\u7b80\u4f53)\",\"languageCode\":\"zh-cn\",\"ianaCode\":\"zh-Hans\",\"isRtl\":false}],\"nativeLanguage\":\"en\",\"isSubtitleRequired\":false,\"resources\":{\"h264\":[{\"bitrate\":1200,\"file\":\"https://py.tedcdn.com/consus/projects/00/53/36/015/products/2021s-kiran-mazumdar-shaw-015-fallback-62a69a4b95991f04045bb0e5119f78be-1200k.mp4\"}],\"hls\":{\"adUrl\":\"https://pubads.g.doubleclick.net/gampad/ads?ciu_szs=300x250%2C512x288%2C120x60%2C320x50%2C6x7%2C6x8&correlator=%5Bcorrelator%5D&cust_params=event%3DTED%40BCG%26id%3D75479%26tag%3Dcollaboration%2CVaccines%2Cpandemic%2Ccoronavirus%2Cindia%2Cmedical%2Bresearch%2Chealth%2Bcare%2Cpublic%2Bhealth%2Cscience%26talk%3Dkiran_mazumdar_shaw_the_global_cooperation_that_accelerated_the_covid_19_vaccines%26year%3D2021&env=vp&gdfp_req=1&impl=s&iu=%2F5641%2Fmobile%2Fios%2Fweb&output=xml_vast2&sz=640x360&unviewed_position_start=1&url=%5Breferrer%5D\",\"maiTargeting\":{\"id\":\"75479\",\"talk\":\"kiran_mazumdar_shaw_the_global_cooperation_that_accelerated_the_covid_19_vaccines\",\"tag\":\"collaboration,Vaccines,pandemic,coronavirus,india,medical research,health care,public health,science\",\"year\":\"2021\",\"event\":\"TED@BCG\"},\"stream\":\"https://hls.ted.com/project_masters/7143/manifest.m3u8?intro_master_id=2346\",\"metadata\":\"https://hls.ted.com/project_masters/7143/metadata.json?intro_master_id=2346\"}},\"targeting\":{\"id\":\"75479\",\"talk\":\"kiran_mazumdar_shaw_the_global_cooperation_that_accelerated_the_covid_19_vaccines\",\"tag\":\"collaboration,Vaccines,pandemic,coronavirus,india,medical research,health care,public health,science\",\"year\":\"2021\",\"event\":\"TED@BCG\"},\"canonical\":\"https://www.ted.com/talks/kiran_mazumdar_shaw_the_global_cooperation_that_accelerated_the_covid_19_vaccines\",\"name\":\"Kiran Mazumdar-Shaw: The global cooperation that accelerated the COVID-19 vaccines\",\"title\":\"The global cooperation that accelerated the COVID-19 vaccines\",\"speaker\":\"Kiran Mazumdar-Shaw\",\"thumb\":\"https://pi.tedcdn.com/r/talkstar-photos.s3.amazonaws.com/uploads/7347a056-4a73-4993-8b50-ed18eeaf0dc1/KiranMazumdar-Shaw_2021S-embed.jpg?quality=89&w=600\",\"slug\":\"kiran_mazumdar_shaw_the_global_cooperation_that_accelerated_the_covid_19_vaccines\",\"event\":\"TED@BCG\",\"published\":1618929657,\"external\":{\"service\":\"YouTube\",\"code\":\"1qHU9cgG9Y4\",\"duration\":0.0,\"start_time\":0.0}}", "videoContext": "TED@BCG", "audioInternalLanguageCode": "en", "language": "en", "hasTranslations": true, "featured": false, "type": {"__typename": "TypeOfVideo", "id": "4", "name": "TED Institute Talk"}}, "transcriptData": {"translation": {"__typename": "Translation", "id": "191871", "language": {"__typename": "Language", "id": "35", "endonym": "English", "englishName": "English", "internalLanguageCode": "en", "rtl": false}, "reviewer": null, "translator": null, "paragraphs": [{"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "Simone Ross: Good morning, Kiran.", "time": 563}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "Kiran Mazumdar-Shaw: Hi, Simone.", "time": 2230}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "SR: Thank you so much\nfor joining us here today.", "time": 3797}, {"__typename": "Cue", "text": "How do you think that the challenges\nof the past year will, sort of --", "time": 6097}, {"__typename": "Cue", "text": "Do you think they will either hinder", "time": 10663}, {"__typename": "Cue", "text": "or improve equitable access\nto health care?", "time": 12430}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "KMS: Well, you know, Simone,\none thing is very clear --", "time": 15130}, {"__typename": "Cue", "text": "that COVID-19 actually pointed out to us\nthat we are all in it together.", "time": 17730}, {"__typename": "Cue", "text": "And I think it also exposed\nmany frailties and fragilities", "time": 24130}, {"__typename": "Cue", "text": "of the health-care systems\naround the world.", "time": 28997}, {"__typename": "Cue", "text": "And, you know, if I may say so,", "time": 32030}, {"__typename": "Cue", "text": "the developing world showed that it had\nbetter primary-care capabilities", "time": 33563}, {"__typename": "Cue", "text": "than the western hemisphere.", "time": 37863}, {"__typename": "Cue", "text": "And this actually has helped them\ncope with the disease", "time": 40097}, {"__typename": "Cue", "text": "I think a little better", "time": 43297}, {"__typename": "Cue", "text": "than what the Western world\nhas struggled with.", "time": 45130}, {"__typename": "Cue", "text": "And it also pointed out that, you know,", "time": 48997}, {"__typename": "Cue", "text": "you cannot be looking after\nyour own small populations", "time": 51563}, {"__typename": "Cue", "text": "and forget about others\nwho are in the neighborhood", "time": 55663}, {"__typename": "Cue", "text": "because you're not safe.", "time": 59130}, {"__typename": "Cue", "text": "And I think from that point of view,", "time": 61030}, {"__typename": "Cue", "text": "this is now becoming\na collective global effort,", "time": 62830}, {"__typename": "Cue", "text": "when it comes to a post-pandemic world,\na post-COVID world,", "time": 67030}, {"__typename": "Cue", "text": "because we will need\nto basically cooperate", "time": 71297}, {"__typename": "Cue", "text": "in terms of surveillance,", "time": 75997}, {"__typename": "Cue", "text": "in terms of prevention\nand in terms of preparedness,", "time": 77963}, {"__typename": "Cue", "text": "in terms of future pandemics.", "time": 81597}, {"__typename": "Cue", "text": "So I think COVID-19\nactually has demonstrated", "time": 84230}, {"__typename": "Cue", "text": "the importance of equitable\nhealth care for all,", "time": 87697}, {"__typename": "Cue", "text": "because if you don't do that,", "time": 92997}, {"__typename": "Cue", "text": "you're not really protecting\nyourselves against it.", "time": 94963}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "And the other point is that, of course,", "time": 98730}, {"__typename": "Cue", "text": "we've seen a large number of initiatives\nunder various umbrellas of WHO,", "time": 100963}, {"__typename": "Cue", "text": "or CEPI, COVAX, the Gates Foundation,\net cetera, et cetera,", "time": 107663}, {"__typename": "Cue", "text": "which really has focused\non stockpiling vaccines", "time": 113163}, {"__typename": "Cue", "text": "for equitable distribution\namongst various countries.", "time": 119330}, {"__typename": "Cue", "text": "So I think all these efforts show you", "time": 123297}, {"__typename": "Cue", "text": "that there is a collective force\nfor global public good", "time": 125930}, {"__typename": "Cue", "text": "that is gaining a lot of acceptance.", "time": 130363}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "SR: I think nothing to sort of show you\nhow interconnected we truly are", "time": 133397}, {"__typename": "Cue", "text": "than a global pandemic.", "time": 137063}, {"__typename": "Cue", "text": "So, you know, it's pretty amazing,", "time": 139463}, {"__typename": "Cue", "text": "almost unbelievable that a year into this,", "time": 143463}, {"__typename": "Cue", "text": "we have multiple vaccines\nthat are rolling out.", "time": 145730}, {"__typename": "Cue", "text": "And as you sort of mentioned,", "time": 148663}, {"__typename": "Cue", "text": "there has been a fair amount\nof cooperation", "time": 150163}, {"__typename": "Cue", "text": "between, certainly it seems,\nin the pharmaceutical industry, on this.", "time": 153330}, {"__typename": "Cue", "text": "Is there anything that has been\nsurprising about that to you?", "time": 158063}, {"__typename": "Cue", "text": "And I'm curious if you have thoughts", "time": 160963}, {"__typename": "Cue", "text": "on what governments can actually learn\nfrom industry on this?", "time": 163530}, {"__typename": "Cue", "text": "Because, as you said, global cooperation\nis really, really important", "time": 166763}, {"__typename": "Cue", "text": "if we're going to get a grip\non this pandemic and future pandemics.", "time": 172430}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "KMS: So, you know,\nthe way I look at this, Simone,", "time": 177730}, {"__typename": "Cue", "text": "is let's look at what\nactually is happening", "time": 180130}, {"__typename": "Cue", "text": "and what happened to begin with.", "time": 182497}, {"__typename": "Cue", "text": "So to begin with, one of the things\nthat we actually learned was", "time": 185363}, {"__typename": "Cue", "text": "the fact that small biotechs\nwere the ones who actually delivered", "time": 188830}, {"__typename": "Cue", "text": "on innovation and innovative vaccines.", "time": 194263}, {"__typename": "Cue", "text": "So whether it was Oxford University,", "time": 196963}, {"__typename": "Cue", "text": "whether it was BioNTech\nand whether it was Moderna", "time": 199297}, {"__typename": "Cue", "text": "and many other biotechs\nlike Novavax, et cetera,", "time": 203163}, {"__typename": "Cue", "text": "I think they were the ones\nwho actually pivoted very rapidly", "time": 207963}, {"__typename": "Cue", "text": "and came up with those early\nvaccine programs,", "time": 211897}, {"__typename": "Cue", "text": "which were then quickly\npartnered with Big Pharma.", "time": 215597}, {"__typename": "Cue", "text": "So Big Pharma actually then decided\nto basically invest and license", "time": 219530}, {"__typename": "Cue", "text": "and develop these programs", "time": 224730}, {"__typename": "Cue", "text": "and take it to global markets\nbecause, you know,", "time": 226897}, {"__typename": "Cue", "text": "they felt that it was Big Pharma\nthat had the kind of necessary networks", "time": 230097}, {"__typename": "Cue", "text": "and supply chains to deliver those\nvaccines efficiently to global markets.", "time": 235730}, {"__typename": "Cue", "text": "And that's where they got a lot of help\nfrom public funding from BARDA and EU", "time": 241130}, {"__typename": "Cue", "text": "and many other sources of funding,\nincluding the Gates Foundation,", "time": 246797}, {"__typename": "Cue", "text": "to basically then deliver these programs", "time": 251263}, {"__typename": "Cue", "text": "to the end-markets\nthat required these vaccines.", "time": 254230}, {"__typename": "Cue", "text": "So that was one very important learning\nthat we had from this pandemic.", "time": 258830}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "The second thing was\nthat after these vaccines were approved,", "time": 264897}, {"__typename": "Cue", "text": "again, some gaps in production came about.", "time": 270130}, {"__typename": "Cue", "text": "And so therefore, suddenly Big Pharma\nstarted partnering with each other,", "time": 275297}, {"__typename": "Cue", "text": "which really hasn't happened before,", "time": 279597}, {"__typename": "Cue", "text": "where, say, Novartis decided\nto help out Pfizer", "time": 281997}, {"__typename": "Cue", "text": "in its manufacturing gaps.", "time": 287297}, {"__typename": "Cue", "text": "And the same thing happened with Merck\nnow trying to help out J an J", "time": 290497}, {"__typename": "Cue", "text": "with its manufacturing needs.", "time": 295230}, {"__typename": "Cue", "text": "So there's been a lot of interesting\npartnerships and collaborations", "time": 297130}, {"__typename": "Cue", "text": "to really address this global challenge.", "time": 301530}, {"__typename": "Cue", "text": "So I think this has been\na really good effort", "time": 303963}, {"__typename": "Cue", "text": "and a great collective effort.", "time": 306863}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "Amidst all this,", "time": 310063}, {"__typename": "Cue", "text": "I also wanted to pitch\nfor what the Indian vaccine industry", "time": 311297}, {"__typename": "Cue", "text": "has done for the world.", "time": 315730}, {"__typename": "Cue", "text": "If you remember, in the early\nstages of the pandemic,", "time": 318997}, {"__typename": "Cue", "text": "we had Indian companies really starting\nto invest in vaccine development.", "time": 322330}, {"__typename": "Cue", "text": "Our largest vaccine maker,\nSerum Institute,", "time": 328930}, {"__typename": "Cue", "text": "in fact partnered with Oxford University\neven before AstraZeneca did.", "time": 332297}, {"__typename": "Cue", "text": "And they agreed to help Oxford University", "time": 337363}, {"__typename": "Cue", "text": "by saying that we will actually\nmanufacture this at risk", "time": 340430}, {"__typename": "Cue", "text": "so that you can start clinical trials.", "time": 343797}, {"__typename": "Cue", "text": "And then, of course,", "time": 346397}, {"__typename": "Cue", "text": "AstraZeneca came into the picture\nand then, you know,", "time": 347563}, {"__typename": "Cue", "text": "Serum Institute is still making very large\nquantities of the vaccines at scale", "time": 352263}, {"__typename": "Cue", "text": "and supplying it to COVAX\nand many other countries", "time": 359163}, {"__typename": "Cue", "text": "who are short-supplied\nin terms of vaccines.", "time": 363197}, {"__typename": "Cue", "text": "Another company, Bharat Biotech,", "time": 366363}, {"__typename": "Cue", "text": "also started developing its own homegrown\nvaccine based on the virus,", "time": 368530}, {"__typename": "Cue", "text": "which was then an inactivated\nvirus-based vaccine,", "time": 375363}, {"__typename": "Cue", "text": "which has also received\nemergency-use authorization in India.", "time": 379130}, {"__typename": "Cue", "text": "And then many other companies are also\npartnering with Novavax and J and J.", "time": 383497}, {"__typename": "Cue", "text": "And there is a quadrilateral\nalliance summit in India", "time": 388963}, {"__typename": "Cue", "text": "between the US, India,\nAustralia and Japan", "time": 395063}, {"__typename": "Cue", "text": "that is actually talking about partnering", "time": 399430}, {"__typename": "Cue", "text": "in this whole pandemic crisis", "time": 401863}, {"__typename": "Cue", "text": "in terms of both surveillance,\nin terms of manufacturing,", "time": 405663}, {"__typename": "Cue", "text": "in terms of vaccine deployment.", "time": 409630}, {"__typename": "Cue", "text": "So I think it's very interesting\nwhat's happening in the world.", "time": 411697}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "And I think India\nhas finally found recognition", "time": 415197}, {"__typename": "Cue", "text": "as a major supplier of vaccines", "time": 418463}, {"__typename": "Cue", "text": "and not just vaccines,\nbut the entire supply chain.", "time": 421130}, {"__typename": "Cue", "text": "We are now recognised\nas the largest producer of vaccines,", "time": 424830}, {"__typename": "Cue", "text": "of syringes, of glass vials, of needles,", "time": 430663}, {"__typename": "Cue", "text": "because that was our original business.", "time": 434463}, {"__typename": "Cue", "text": "India was vaccinating the world,", "time": 437430}, {"__typename": "Cue", "text": "but it was actually vaccinating\nlow and middle-income countries", "time": 439930}, {"__typename": "Cue", "text": "for the kind of vaccines\nthat you normally deploy worldwide", "time": 444730}, {"__typename": "Cue", "text": "to immunize children.", "time": 449797}, {"__typename": "Cue", "text": "Today, I think it has pivoted", "time": 451897}, {"__typename": "Cue", "text": "and it has gotten recognised as a major\nvaccine producer in the world.", "time": 454130}, {"__typename": "Cue", "text": "So I think it's important\nfor us to recognize", "time": 458097}, {"__typename": "Cue", "text": "that India is a very critical part\nof the global supply chain", "time": 461197}, {"__typename": "Cue", "text": "when it comes to vaccines", "time": 466763}, {"__typename": "Cue", "text": "and even generic medicines,\nfor that matter.", "time": 468263}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "SR: Many countries in the developing world\nhave actually done very well", "time": 471063}, {"__typename": "Cue", "text": "in controlling the virus,\nin controlling COVID-19,", "time": 474430}, {"__typename": "Cue", "text": "and has gotten somewhat better\nthan other parts of the world.", "time": 477363}, {"__typename": "Cue", "text": "Do you think there's something\ncultural in that?", "time": 480463}, {"__typename": "Cue", "text": "Because the other thing\nyou talked about at Berkeley", "time": 482730}, {"__typename": "Cue", "text": "was sort of, the difference between\nthe pharma industry in India", "time": 485230}, {"__typename": "Cue", "text": "versus the rest of the world.", "time": 488463}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "KMS: So you know,", "time": 490297}, {"__typename": "Cue", "text": "there are a number of hypotheses", "time": 491497}, {"__typename": "Cue", "text": "in terms of why did the developing world\nmanage COVID better", "time": 493397}, {"__typename": "Cue", "text": "than other parts of the world,", "time": 497830}, {"__typename": "Cue", "text": "especially Asia, I would say.", "time": 499297}, {"__typename": "Cue", "text": "And I think the reason is\nthat there are many, many factors.", "time": 501797}, {"__typename": "Cue", "text": "One is that we are\na young population, you know,", "time": 505197}, {"__typename": "Cue", "text": "so I think our demographics\nhave played to our advantage.", "time": 508230}, {"__typename": "Cue", "text": "I think what has also helped us a lot", "time": 512030}, {"__typename": "Cue", "text": "is that unlike the rigidity\nof standard of care protocols", "time": 515163}, {"__typename": "Cue", "text": "in many advanced parts of the world,", "time": 520197}, {"__typename": "Cue", "text": "I think Indian doctors are very ready\nto experiment with therapies", "time": 523263}, {"__typename": "Cue", "text": "that can work.", "time": 528463}, {"__typename": "Cue", "text": "Now, for instance, this is a new virus.", "time": 529697}, {"__typename": "Cue", "text": "This was a new disease.", "time": 531697}, {"__typename": "Cue", "text": "And if you are very stuck\non standard of care protocols,", "time": 533430}, {"__typename": "Cue", "text": "which may not work for this disease,", "time": 538530}, {"__typename": "Cue", "text": "then you're actually\nnot giving yourself a fair chance", "time": 540730}, {"__typename": "Cue", "text": "to deal with the disease\nin a more optimal way.", "time": 545030}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "In India, I think we have\nan excellent medical community,", "time": 548430}, {"__typename": "Cue", "text": "we have great doctors.", "time": 552697}, {"__typename": "Cue", "text": "And these doctors\nwere actually willing to experiment", "time": 554297}, {"__typename": "Cue", "text": "with anything that could save patients.", "time": 557530}, {"__typename": "Cue", "text": "And what I mean by that is\nway before WHO prescribed steroids", "time": 560997}, {"__typename": "Cue", "text": "as one of the important interventions\nfor hyper immune responses,", "time": 567130}, {"__typename": "Cue", "text": "I mean, Indian doctors were using steroids\nright at the start of the disease, OK?", "time": 572863}, {"__typename": "Cue", "text": "And then we were trying\neverything possible in a very logical way,", "time": 579363}, {"__typename": "Cue", "text": "whether it was basically blood thinners,", "time": 584363}, {"__typename": "Cue", "text": "whether it was low molecular weight\nheparins to prevent clotting.", "time": 587963}, {"__typename": "Cue", "text": "As they learned about how this\ndisease was working,", "time": 592363}, {"__typename": "Cue", "text": "they were willing to use\nthese kind of therapeutics", "time": 594997}, {"__typename": "Cue", "text": "to try and deal with these patients\nand their problems.", "time": 598597}, {"__typename": "Cue", "text": "So I think this has helped a lot.", "time": 602397}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "SR: I'm curious.", "time": 604763}, {"__typename": "Cue", "text": "So you're an entrepreneur,", "time": 606063}, {"__typename": "Cue", "text": "although maybe you don't consider\nyourself one now,", "time": 608097}, {"__typename": "Cue", "text": "but you did start your company,\nI've read, in a garage,", "time": 610563}, {"__typename": "Cue", "text": "which often you hear\nas part of the start-up law,", "time": 613963}, {"__typename": "Cue", "text": "certainly here in the US.", "time": 619663}, {"__typename": "Cue", "text": "I'm curious what advice you might have\nfor a young biotech entrepreneur now.", "time": 621663}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "KMS: Well, you know,", "time": 628363}, {"__typename": "Cue", "text": "I would say this is the most\nexciting time for a biotech start-up,", "time": 629563}, {"__typename": "Cue", "text": "because you can see that, you know,", "time": 633763}, {"__typename": "Cue", "text": "a lot of the new ideas are actually coming\nout of small biotech start-ups.", "time": 636830}, {"__typename": "Cue", "text": "And as you heard, BioNTech\nwas actually struggling to survive", "time": 642463}, {"__typename": "Cue", "text": "and suddenly COVID has made them", "time": 648130}, {"__typename": "Cue", "text": "into a multibillion-dollar\nbiotech company today.", "time": 650163}, {"__typename": "Cue", "text": "So I think, you know,", "time": 654430}, {"__typename": "Cue", "text": "we must understand that any idea\ncan be a blockbuster idea.", "time": 655630}, {"__typename": "Cue", "text": "And you shouldn't give up on these ideas.", "time": 662163}, {"__typename": "Cue", "text": "And to me, you know,", "time": 664530}, {"__typename": "Cue", "text": "entrepreneurship in the tech space\nis the most exciting space to be in.", "time": 666130}, {"__typename": "Cue", "text": "And I just feel that there are\nso many challenges", "time": 671230}, {"__typename": "Cue", "text": "and so many unmet needs", "time": 674663}, {"__typename": "Cue", "text": "that in our field of biotechnology,\nI think, you know ...", "time": 676863}, {"__typename": "Cue", "text": "There's umpteen number\nof opportunities to be successful.", "time": 683597}, {"__typename": "Cue", "text": "So really, the world is your oyster.", "time": 687630}, {"__typename": "Cue", "text": "And I think, you know,", "time": 689597}, {"__typename": "Cue", "text": "this couldn't be a better time\nto be an entrepreneur in the tech world,", "time": 691363}, {"__typename": "Cue", "text": "whether it's information technology\nor biotechnology or any tech space,", "time": 696163}, {"__typename": "Cue", "text": "I think it\u2019s a very exciting time.", "time": 701230}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "Because today it\u2019s not just about biotech,", "time": 703663}, {"__typename": "Cue", "text": "it's also about the opportunities in AI,", "time": 706230}, {"__typename": "Cue", "text": "in, you know, in the kind of,\nIOTs and many, many other areas", "time": 711897}, {"__typename": "Cue", "text": "which are actually leveraging\ninformation technologies", "time": 717063}, {"__typename": "Cue", "text": "for various applications.", "time": 720797}, {"__typename": "Cue", "text": "I mean, you think about work from home,", "time": 722463}, {"__typename": "Cue", "text": "which has happened during the pandemic,", "time": 724863}, {"__typename": "Cue", "text": "and, you know, technology\nand technology-based companies", "time": 727330}, {"__typename": "Cue", "text": "are just, you know,\nfinding so many opportunities.", "time": 730530}, {"__typename": "Cue", "text": "Who had heard of Zoom\ntill the pandemic broke out?", "time": 733697}, {"__typename": "Cue", "text": "You know, things like that.", "time": 737463}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "SR: That's true.", "time": 739063}, {"__typename": "Cue", "text": "I'm curious, so you mentioned\nsort of blockbusters", "time": 741197}, {"__typename": "Cue", "text": "and that's something else\nthat you talked about a little bit", "time": 744663}, {"__typename": "Cue", "text": "a couple of days ago.", "time": 747997}, {"__typename": "Cue", "text": "You said for some companies,", "time": 749263}, {"__typename": "Cue", "text": "sort of a blockbuster drug\nis a one-billion-dollar treatment,", "time": 751763}, {"__typename": "Cue", "text": "but that for you, a blockbuster is\nit reaches one billion people.", "time": 755563}, {"__typename": "Cue", "text": "Can you talk about that a little bit?", "time": 759830}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "KMS: Yeah, you know,", "time": 762863}, {"__typename": "Cue", "text": "I've always felt that the Western model,", "time": 764063}, {"__typename": "Cue", "text": "in terms of the pharmaceutical industry,", "time": 768697}, {"__typename": "Cue", "text": "has always been to serve\na small population", "time": 772130}, {"__typename": "Cue", "text": "which is affluent and which can pay\na lot for the drug.", "time": 776763}, {"__typename": "Cue", "text": "So it's been about a high-value,\nlow-volume, kind of a business model.", "time": 780963}, {"__typename": "Cue", "text": "Whereas when you live in a country\nlike India, with over a billion people,", "time": 787063}, {"__typename": "Cue", "text": "and you're trying to basically address\nthe unmet medical needs", "time": 791697}, {"__typename": "Cue", "text": "of such a large population,", "time": 796563}, {"__typename": "Cue", "text": "it has to be about economies of scale.", "time": 798830}, {"__typename": "Cue", "text": "It has to be about serving\na large population base.", "time": 801630}, {"__typename": "Cue", "text": "So, for instance,", "time": 806297}, {"__typename": "Cue", "text": "we are an insulin-producing company.", "time": 807497}, {"__typename": "Cue", "text": "And when I look at producing insulin,\nit has to be affordable", "time": 810997}, {"__typename": "Cue", "text": "and accessible to a billion people\nat least who need that insulin.", "time": 816930}, {"__typename": "Cue", "text": "So that's what I mean\nby saying that for me,", "time": 821230}, {"__typename": "Cue", "text": "a blockbuster drug is about serving\nat least a billion patients,", "time": 823897}, {"__typename": "Cue", "text": "not about a billion dollars,", "time": 827530}, {"__typename": "Cue", "text": "because the moment you serve\na billion patients anyway,", "time": 829463}, {"__typename": "Cue", "text": "it's going to be over a billion\ndollars of an opportunity.", "time": 832363}, {"__typename": "Cue", "text": "So to me, it's about patients first\nand business will follow.", "time": 835963}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "SR: Kiran, thank you so much\nfor talking to me today.", "time": 839763}, {"__typename": "Cue", "text": "This was great. Thank you.", "time": 842297}]}, {"__typename": "Paragraph", "cues": [{"__typename": "Cue", "text": "KMS: Thank you, Simone.", "time": 844197}]}]}, "video": {"__typename": "Video", "id": "75479", "talkExtras": {"__typename": "TalkExtras", "footnotes": [{"__typename": "Footnote", "author": null, "annotation": "> \"And you know, if I may say so, the developing world showed that it had better primary care capabilities than the Western Hemisphere. And this actually has helped them cope with the disease, I think, a little better than what the Western world has struggled with.\"\r\n\r\nClarification: For more on case numbers in developing nations, and concerns that underreporting could be among the factors at play, see [here](https://unctad.org/system/files/official-document/ldcr2020_ch1_en.pdf).", "date": null, "linkUrl": null, "source": null, "text": null, "timecode": "", "title": null, "category": "note"}, {"__typename": "Footnote", "author": null, "annotation": "> \"So you know, there are a number of hypotheses, in terms of why did the developing world manage COVID better than other parts of the world, especially Asia, I would say. And I think the reason is that there are many, many factors. One is that we are a young population, you know? So I think our demographics have played to our advantage.\"\r\n\r\nClarification: there are many critics of the hypotheses on India's handling of COVID-19 and the potential for low virus rates to be related to underreporting. For more, see [here](https://www.sciencemag.org/news/2020/10/indias-covid-19-cases-have-declined-rapidly-herd-immunity-still-far-away-scientists-say) and [here](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399343/).", "date": null, "linkUrl": null, "source": null, "text": null, "timecode": "", "title": null, "category": "note"}, {"__typename": "Footnote", "author": null, "annotation": "> \"And finally, I think what has also helped us a lot is that unlike the rigidity of standard-of-care protocols in many advanced parts of the world. I think Indian doctors are very ready to experiment with therapies that can work. Now, for instance, this is a new virus. This was a new disease. And if you are very stuck on standard operation, you know standard-of-care protocols, which may not work for this disease, then you're actually not giving yourself a fair chance to deal with the disease in a more optimal way. In India, I think we have an excellent medical community. We have great doctors, and these doctors were actually willing to experiment with anything that could save patients. And what I mean by that is -- way before WHO prescribed steroids as one of the important interventions for hyperimmune responses -- I mean, Indian doctors were using steroids, right at the start of the disease. Okay? And then we were trying everything possible, in a very logical way, whether it was basically blood thinners, whether it was low-molecular-weight heparin to prevent clotting. As they learn about how this disease was working, they were willing to use these kind of therapeutics to try and deal with these patients and their problems. So I think this has helped a lot.\"\r\n\r\nClarification: For more on debate over the experimental treatment used in the region, see [here](https://www.nature.com/articles/d41586-020-03105-7).", "date": null, "linkUrl": null, "source": null, "text": null, "timecode": "", "title": null, "category": "note"}, {"__typename": "Footnote", "author": null, "annotation": "> \"And I think if you look at a country of our size, and if you look at the kind of mortality rates and the kind of infection rates and the case fatality rates, it's really really quite commendable that we haven't had a worse attack of this pandemic.\"\r\n\r\nClarification: There are concerns among the scientific community that India may have underreported or undercounted COVID-19-related deaths in the region. For more on that, see [here](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399343/).", "date": null, "linkUrl": null, "source": null, "text": null, "timecode": "", "title": null, "category": "note"}, {"__typename": "Footnote", "author": null, "annotation": "> \"We are now recognized as the largest producer of vaccines, of syringes, of glass vials, of needles, because that was our original business.\"\r\n\r\nClarification: According to a Research and Market's report from November 2020, New Jersey-based company, Becton, Dickinson and Company (BD), may hold this title. For more on this, see [here](https://www.researchandmarkets.com/reports/5135119/syringe-and-needle-market-global-outlook-and#pos-1) and [here](https://www.nsmedicaldevices.com/analysis/biggest-needle-syringe-manufacturers-companies/).", "date": null, "linkUrl": null, "source": null, "text": null, "timecode": "", "title": null, "category": "note"}]}}}, "commentsEnabled": false, "commentsLoggedInOnly": false}, "language": "en", "messages": {}, "responseCode": 200, "__N_SSP": true}